SCHEMBL20081378

SCHEMBL20081378

CCc1nc2ccc(F)cc2c(=O)n1-c1cccnc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX12 P18054 1/20 0.53
▸ RAB9A P51151 1/20 0.51
▸ PIK3CD O00329 1/20 0.49
▸ MAPT P10636 3/20 0.48
▸ MDM2 Q00987 1/20 0.48
▸ GAA P10253 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ TDO2 P48775 2/20 0.46
▸ IDO2 Q6ZQW0 2/20 0.46
▸ HDAC1 Q13547 1/20 0.45
▸ HDAC8 Q9BY41 1/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ MAPK14 Q16539 2/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ IDO1 P14902 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ METAP2 P50579 1/20 0.44
▸ CYP11B1 P15538 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16854205 0.88 HDAC1 (0.55) RAB9ATDO2IDO2HDAC1HDAC8
SCHEMBL20081318 0.87 ALOX12 (0.70) ALOX12PIK3CDMDM2TDO2IDO2
SCHEMBL20081376 0.85 HPD (0.49) TDO2IDO2HDAC1HDAC8HDAC6
SCHEMBL20081302 0.83 POLB (0.52) MAPTTDO2IDO2HDAC1HDAC8
SCHEMBL20067856 0.81 PIK3CD (0.61) ALOX12PIK3CDMDM2TDO2IDO2
SCHEMBL19992063 0.80 PIK3CD (0.51) ALOX12RAB9APIK3CDMAPTMDM2
SCHEMBL16293498 0.80 PIK3CD (0.61) ALOX12PIK3CDMDM2TDO2IDO2
SCHEMBL16293497 0.80 PIK3CD (0.61) ALOX12PIK3CDMDM2TDO2IDO2
SCHEMBL24090095 0.77 PIK3CD (0.50) ALOX12RAB9APIK3CDMAPTMDM2
SCHEMBL30103245 0.77 PIK3CD (0.50) ALOX12RAB9APIK3CDMDM2TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3312175-A1 HETEROARYL DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH PI3 KINASES, CONTAINING SAME AS ACTIVE INGREDIENT Korea Research Institute of Chemical Technology (KR) 2018-04-25 — — EP disclosed
Send feedback